Form 4 for HCWB HCW Biologics Inc.
Accepted 2022-01-19 00:00:00 ET · period of report 2022-01-14 · accession 0001209191-22-003785 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-01-19 | 2022-01-14 | HCWB | Rhode Peter | See Remarks | M - OptEx | $0.21 | +1,715 | 48.5K | +4% | +$360.08 |
| DM | 2022-01-19 | 2022-01-14 | HCWB | Rhode Peter | See Remarks | M - OptEx | $0.00 | -1,715 | 6,857 | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-14 | M | A | 1 | $0.14 | 48,500 | D | — | — | |
| 2 | Common | Common Stock | 2022-01-14 | M | A | 1,714 | $0.21 | 48,499 | D | — | — | |
| 3 | Derivative | Stock Option Grant (Right to Buy) | 2022-01-14 | M | D | 1 | $0.00 | 51,427 | D | $0.14 · — to 2029-12-19 | 1 Common Stock | (F2) These option shares were part of a stock option grant covering 85,713 shares of common stock. 20% of the total shares subject to the stock option grant vested on May 30, 2020; 20% of the total shares subject to the stock option grant vested on May 30, 2021; 25% of the total shares subject to the stock option grant will vest on May 30, 2022; and 35% of the total shares subject to the stock option grant will vest on May 30, 2023, subject to the reporting person's continuous service through the applicable vesting date. |
| 4 | Derivative | Stock Option Grant (Right to Buy) | 2022-01-14 | M | D | 1,714 | $0.00 | 6,857 | D | $0.21 · — to 2030-12-22 | 1,714 Common Stock | (F1) 20% of the total shares subject to the stock option grant vested on December 22, 2021; 20% of the total shares subject to the stock option grant will vest on December 22, 2022; 25% of the total shares subject to the stock option grant will vest on December 22, 2023; and 35% of the total shares subject to the stock option grant will vest on December 22, 2024, subject to the reporting person's continuous service through the applicable vesting date. |